Observation of the therapeutic effect of qianlie sanyu capsule on benign prostatic hyperplasia.
- Author:
Jian-yuan XI
1
;
Ju-qiao HE
;
Xi ZHANG
;
Li-fang LIU
;
Fang-guo LU
Author Information
- Publication Type:Journal Article
- MeSH: Capsules; Drugs, Chinese Herbal; therapeutic use; Humans; Male; Phytotherapy; Prostatic Hyperplasia; drug therapy
- From: National Journal of Andrology 2005;11(1):68-75
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the clinical efficacy of Qianlie Sanyu Capsule on benign prostatic hyperplasia (BPH).
METHODSSeventy-two patients with BPH were randomly divided into a treatment group (40 patients) and a control group (32 patients), the former treated by Qianlie Sanyu Capsule and the latter by Longbishu. Observation were made on the changes of the patients' urination' symptoms, living quality, prostatic volume, Qmax uroflowmetry and excel urine before and after treatment.
RESULTSThe total efficacy rates were 92.5% in the treatment group, and 72.5% in the control group. Comparison between the two groups showed significant difference (P < 0.01). The urination symptoms, living quality, Qmax uroflowmetry and the excel urine were better improved in the Qianlie Sanyu group than in the Longbishu. There were significant differences between the two groups (P < 0.05), but none in reducing effect on the prostatic volume.
CONCLUSIONQianlie Sanyu Capsule is an effective drug for BPH.
